Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janet Wittes

Showing results (101-110 of 122) with videos related to

Pageof 13
Sort By:
Vaccine|January 4, 2006
Phase 1 randomized double-blind safety and immunogenicity trial of Plasmodium falciparum malaria merozoite surface protein FMP1 vaccine, adjuvanted with AS02A, in adults in western KenyaJosé A Stoute, Joash Gombe, Mark R Withers, et al.
Vaccine|April 23, 2003
Efficacy trial of live, cold-adapted and inactivated influenza virus vaccines in older adults with chronic obstructive pulmonary disease: a VA cooperative studyGeoffrey J Gorse, Theresa Z O'Connor, Stephen L Young, et al.
Clinical Trials (London, England)|February 1, 2017
RejoinderThomas R Fleming, David L DeMets, Matthew T Roe, et al.
American Heart Journal|June 18, 2018
High-dose influenza vaccine to reduce clinical outcomes in high-risk cardiovascular patients: Rationale and design of the INVESTED trialOrly Vardeny, Jacob A Udell, Jacob Joseph, et al.
JACC. Heart Failure|January 6, 2026
Subgroups and Special Populations in Heart Failure Clinical Trials: Insights From the HFC-ARC Expert Consensus PanelVanessa Blumer, Biykem Bozkurt, Marvin A Konstam, et al.
Clinical Trials (London, England)|April 1, 2017
Data monitoring committees: Promoting best practices to address emerging challengesThomas R Fleming, David L DeMets, Matthew T Roe, et al.
American Heart Journal|November 1, 2020
Cardiovascular safety and efficacy of vadadustat for the treatment of anemia in non-dialysis-dependent CKD: Design and baseline characteristicsGlenn M Chertow, Pablo E Pergola, Rajiv Agarwal, et al.
JACC. Heart Failure|December 1, 2022
Functional and Symptomatic Clinical Trial Endpoints: The HFC-ARC Scientific Expert PanelMitchell A Psotka, William T Abraham, Mona Fiuzat, et al.
Plos Clinical Trials|November 25, 2006
Safety and reactogenicity of an MSP-1 malaria vaccine candidate: a randomized phase Ib dose-escalation trial in Kenyan childrenMark R Withers, Denise McKinney, Bernhards R Ogutu, et al.
The New England Journal of Medicine|September 1, 2006
Celecoxib for the prevention of sporadic colorectal adenomasMonica M Bertagnolli, Craig J Eagle, Ann G Zauber, et al.
Pageof 13

Showing results (101-110 of 122) with videos related to

Sort By:
Pageof 13
Vaccine|January 4, 2006
Phase 1 randomized double-blind safety and immunogenicity trial of Plasmodium falciparum malaria merozoite surface protein FMP1 vaccine, adjuvanted with AS02A, in adults in western KenyaJosé A Stoute, Joash Gombe, Mark R Withers, et al.
Vaccine|April 23, 2003
Efficacy trial of live, cold-adapted and inactivated influenza virus vaccines in older adults with chronic obstructive pulmonary disease: a VA cooperative studyGeoffrey J Gorse, Theresa Z O'Connor, Stephen L Young, et al.
Clinical Trials (London, England)|February 1, 2017
RejoinderThomas R Fleming, David L DeMets, Matthew T Roe, et al.
American Heart Journal|June 18, 2018
High-dose influenza vaccine to reduce clinical outcomes in high-risk cardiovascular patients: Rationale and design of the INVESTED trialOrly Vardeny, Jacob A Udell, Jacob Joseph, et al.
JACC. Heart Failure|January 6, 2026
Subgroups and Special Populations in Heart Failure Clinical Trials: Insights From the HFC-ARC Expert Consensus PanelVanessa Blumer, Biykem Bozkurt, Marvin A Konstam, et al.
Clinical Trials (London, England)|April 1, 2017
Data monitoring committees: Promoting best practices to address emerging challengesThomas R Fleming, David L DeMets, Matthew T Roe, et al.
American Heart Journal|November 1, 2020
Cardiovascular safety and efficacy of vadadustat for the treatment of anemia in non-dialysis-dependent CKD: Design and baseline characteristicsGlenn M Chertow, Pablo E Pergola, Rajiv Agarwal, et al.
JACC. Heart Failure|December 1, 2022
Functional and Symptomatic Clinical Trial Endpoints: The HFC-ARC Scientific Expert PanelMitchell A Psotka, William T Abraham, Mona Fiuzat, et al.
Plos Clinical Trials|November 25, 2006
Safety and reactogenicity of an MSP-1 malaria vaccine candidate: a randomized phase Ib dose-escalation trial in Kenyan childrenMark R Withers, Denise McKinney, Bernhards R Ogutu, et al.
The New England Journal of Medicine|September 1, 2006
Celecoxib for the prevention of sporadic colorectal adenomasMonica M Bertagnolli, Craig J Eagle, Ann G Zauber, et al.
Pageof 13